vimarsana.com

Page 19 - Emerging Science News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Astrazeneca - Eplontersen demonstrated sustained benefit in Phase III trial for hereditary transthyretin-mediated amyloid polyneuropathy through 66 weeks

New organ-on-chip pilot seeks to reduce animal testing in consumer health industry

A first-of-its-kind collaboration in the consumer health industry is developing a platform aimed at reducing or replacing animal testing using “organ-on-chip” (OoC) technology and interactive computational software. The pilot project, supported by esqLABS, Dynamic42, Placenta Lab of Jena University Hospital, and .

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.